From a Washington University School of Medicine news release:
A blood test to detect the brain changes of early Alzheimer’s disease has moved one step closer to reality. Researchers from Washington University School of Medicine in St. Louis report that they can measure levels of the Alzheimer’s protein amyloid beta in the blood and use such levels to predict whether the protein has accumulated in the brain. The findings represent a key step toward a blood test to diagnose people on track to develop the devastating disease before symptoms arise.
Up to two decades before people develop the characteristic memory loss and confusion of Alzheimer’s disease, damaging clumps of protein start to build up in their brains. Now, a blood test to detect such early brain changes has moved one step closer to clinical use.
Researchers from Washington University School of Medicine in St. Louis report that they can measure levels of the Alzheimer’s protein amyloid beta in the blood and use such levels to predict whether the protein has accumulated in the brain. When blood amyloid levels are combined with two other major Alzheimer’s risk factors – age and the presence of the genetic variant APOE4 – people with early Alzheimer’s brain changes can be identified with 94% accuracy, the study found.
To read more click on following link: https://medicine.wustl.edu/news/blood-test-is-94-accurate-at-identifying-early-alzheimers-disease/
Syndicated columnist Mark Shields and New York Times columnist David Brooks join Judy Woodruff to discuss the week’s political news, including President Trump’s personal attacks on Democratic Rep. Elijah Cummings of Maryland and other lawmakers of color, the significance of a wave of Republican congressional retirements and how the 2020 Democrats fared in the two-night debate in Detroit.
“A healthy diet and lifestyle are generally recognized as good for health, but this study is the first large randomized controlled trial to look at whether lifestyle changes actually influence Alzheimer’s disease-related brain changes,” said Susan Landau, a research neuroscientist at Berkeley’s Helen Wills Neuroscience Institute, and principal investigator of the add-on study.
Mr. Ergen also argues wireless pricing is broken. He says U.S. carriers have many customers paying for unlimited data plans they don’t need, much as cable companies long forced subscribers to pay for big bundles of TV channels.
Syndicated columnist Mark Shields and New York Times columnist David Brooks join Judy Woodruff to discuss the week’s political news, including the aftermath of Robert Mueller’s congressional testimony, the current legislative landscape around election security, changing dynamics within the 2020 presidential race and the fiscal significance of the bipartisan budget deal.


I once witnessed the care of a patient who suffered from chronic obstructive pulmonary disease, which blocks airflow to lungs and makes it difficult to breathe. Over the course of a particularly hot Texas summer, he was admitted to the hospital time and time again—racking up more than $60,000 in medical expenses. Doctors were treating his breathing problems repeatedly, but they did not understand why the patient continued to have trouble.
Syndicated columnist Mark Shields and New York Times columnist David Brooks join Judy Woodruff to discuss the week’s political news, including President Trump’s attack on four congresswomen of color, the Republican response to Trump’s controversial rhetoric, whether race politics is smart election strategy and the battle over health care policy among 2020 Democrats.
“Knee replacement is increasing in frequency, and it has an associated substantial cost implication to any health-care provider. It is also essential that patients receive the most efficacious operation for this condition. Before our study, and despite several cohort-based reports, knowledge of whether one operation type is superior, remained uncertain. Our 5-year study has indicated that both TKR and PKR are beneficial interventions but, based on our combined clinical and cost-effectiveness data and providing the operation is performed by those with adequate experience, we recommend that PKR should be offered as the treatment of choice for late-stage isolated medial compartment osteoarthritis of the knee.
Syndicated columnist Mark Shields and The National Review’s Ramesh Ponnuru join Judy Woodruff to discuss the latest in politics, including brewing tensions between progressive and moderate House Democrats, President Trump’s executive action on acquiring citizenship data, the role of money in politics and remembering Ross Perot.